Khavinson Peptides: The Complete Guide to the Most Underestimated Longevity Research in the World
By RUOcodes.com Research Team
Published: · Updated: Sep 6, 2026
Complete guide to Khavinson bioregulator peptides: Epitalon, Bronchogen, Cardiogen, Cortagen, and more — mechanisms and longevity research.
For research and educational purposes only. Not medical advice. There is a body of scientific work spanning more than four decades, 775 peer-reviewed publications, 196 patents, a Nobel Prize nomination, six approved pharmaceutical products, and clinical data covering over 15 million patients across Russia and Eastern Europe. It involves compounds that produced a four-fold reduction in mortality in a human cohort study. It is backed by research showing direct interaction with DNA regulatory sequences in specific organ tissues. Most people in the Western biohacking and longevity community have never heard of it. That is changing in 2026, and for good reason. Khavinson peptides, also called peptide bioregulators, are now among the most searched longevity compounds in the research community. Epitalon is scheduled for its first formal FDA advisory committee review on July 24, 2026. US capital is entering the space, with startups openly building on the Khavinson research foundation. The conversation that has been happening quietly in specialist circles for twenty years is finally going mainstream. This is the most comprehensive English-language overview of Khavinson peptides available, covering who Vladimir Khavinson was, how bioregulators work at the cellular level, the complete catalog of compounds and what the research says about each, the honest assessment of where the evidence is strong and where it is not, and what the regulatory landscape looks like heading into the second half of 2026. WHO WAS VLADIMIR KHAVINSON Vladimir Khavinson was a Russian gerontologist, physician, and scientist who spent more than four decades studying short-chain peptides and their effects on aging, organ function, and longevity. He directed the Saint Petersburg Institute of Bioregulation and Gerontology, which became the world's foremost research center for bioregulator peptide science. He served as president of the European Association of Gerontology and Geriatrics. His research career be…
← Back to Blog